Blocking of mononuclear cell activation by lonazolac.

Abstract	The immunological effect of lonazolac on mononuclear cell activation has been investigated using the indirect Leukocyte Adherence Inhibition Test in Arthritis. Under these conditions, the mononuclear cell response to a synovial stimulus can be abolished by very low concentrations of lonazolac, a new nonsteroidal antiinflammatory drug. This blockade can be completely released by the addition of prostaglandin E2. Lonazolac appears therefore as an agent able in addition to modulate the immune response.
Authors	R Görtz, T Appelboom
Journal	International journal of tissue reactions (Int J Tissue React) Vol. 7 Issue 4 Pg. 263-5 ( 1985) ISSN: 0250-0868 [Print] Switzerland
PMID	3864763 (Publication Type: Journal Article)
Chemical References	Prostaglandins E Pyrazoles lonazolac Dinoprostone
Topics	Arthritis (immunology) Cell Adhesion (drug effects) Dinoprostone Humans Kinetics Monocytes (drug effects, immunology) Prostaglandins E (pharmacology) Pyrazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!